Đurić, M.

Link to this page

Authority KeyName Variants
a692e9ae-e7b6-4cbe-b5a6-d5488779bf0e
  • Đurić, M. (4)
Projects

Author's Bibliography

Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?

Antić, Svetlana; Saveljić, Igor; Nikolić, D.; Jovicić, G.; Filipović, N.; Rakočević, Zoran; Đurić, M.

(Churchill Livingstone, Edinburgh, 2016)

TY  - JOUR
AU  - Antić, Svetlana
AU  - Saveljić, Igor
AU  - Nikolić, D.
AU  - Jovicić, G.
AU  - Filipović, N.
AU  - Rakočević, Zoran
AU  - Đurić, M.
PY  - 2016
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2167
AB  - It has been suggested that unerupted lower third molars (M3) increase the fragility of the mandibular angle and simultaneously decrease the risk of condylar fracture. However, it is unknown whether this applies regardless of the direction and point of impact of the traumatic force. The aim of this study was to investigate the impact of an unerupted M3 on the fragility of the angle and condyle in terms of a force acting from different directions and affecting different regions of the mandible. Computed tomography scans of a human mandible and finite element methodology were used to obtain two three-dimensional models: a model with, and the other without an unerupted M3. A force of 2000 N was applied to three different regions of the models: the symphysis, ipsilateral body, and contralateral body, respectively. When the force was applied to the mandibular body, the results revealed increased angle fragility in cases with unerupted M3. When the force was applied to the symphysis, the condyle region showed higher fragility, irrespective of the presence of an unerupted M3. In summary, fragility of the angle and condyle regions depends on the presence of an unerupted M3 and on the direction and point of impact of the force.
PB  - Churchill Livingstone, Edinburgh
T2  - International Journal of Oral & Maxillofacial Surgery
T1  - Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?
VL  - 45
IS  - 5
SP  - 588
EP  - 592
DO  - 10.1016/j.ijom.2014.09.018
ER  - 
@article{
author = "Antić, Svetlana and Saveljić, Igor and Nikolić, D. and Jovicić, G. and Filipović, N. and Rakočević, Zoran and Đurić, M.",
year = "2016",
abstract = "It has been suggested that unerupted lower third molars (M3) increase the fragility of the mandibular angle and simultaneously decrease the risk of condylar fracture. However, it is unknown whether this applies regardless of the direction and point of impact of the traumatic force. The aim of this study was to investigate the impact of an unerupted M3 on the fragility of the angle and condyle in terms of a force acting from different directions and affecting different regions of the mandible. Computed tomography scans of a human mandible and finite element methodology were used to obtain two three-dimensional models: a model with, and the other without an unerupted M3. A force of 2000 N was applied to three different regions of the models: the symphysis, ipsilateral body, and contralateral body, respectively. When the force was applied to the mandibular body, the results revealed increased angle fragility in cases with unerupted M3. When the force was applied to the symphysis, the condyle region showed higher fragility, irrespective of the presence of an unerupted M3. In summary, fragility of the angle and condyle regions depends on the presence of an unerupted M3 and on the direction and point of impact of the force.",
publisher = "Churchill Livingstone, Edinburgh",
journal = "International Journal of Oral & Maxillofacial Surgery",
title = "Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?",
volume = "45",
number = "5",
pages = "588-592",
doi = "10.1016/j.ijom.2014.09.018"
}
Antić, S., Saveljić, I., Nikolić, D., Jovicić, G., Filipović, N., Rakočević, Z.,& Đurić, M.. (2016). Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?. in International Journal of Oral & Maxillofacial Surgery
Churchill Livingstone, Edinburgh., 45(5), 588-592.
https://doi.org/10.1016/j.ijom.2014.09.018
Antić S, Saveljić I, Nikolić D, Jovicić G, Filipović N, Rakočević Z, Đurić M. Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?. in International Journal of Oral & Maxillofacial Surgery. 2016;45(5):588-592.
doi:10.1016/j.ijom.2014.09.018 .
Antić, Svetlana, Saveljić, Igor, Nikolić, D., Jovicić, G., Filipović, N., Rakočević, Zoran, Đurić, M., "Does the presence of an unerupted lower third molar influence the risk of mandibular angle and condylar fractures?" in International Journal of Oral & Maxillofacial Surgery, 45, no. 5 (2016):588-592,
https://doi.org/10.1016/j.ijom.2014.09.018 . .
18
11
22

Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus

Hadži-Mihailović, Miloš; Raybaud, Helene; Montei, R.; Čakić, Saša; Đurić, M.; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2010)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Raybaud, Helene
AU  - Montei, R.
AU  - Čakić, Saša
AU  - Đurić, M.
AU  - Janković, Ljiljana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1591
AB  - Purpose: The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of the expression of the Bcl-2 marker in healthy individuals (H), patients with OLP and patients with squamous cell carcinoma (SCC), and to establish potential interdependence between expression of Bcl-2 and the different clinical and histopathological parameters in H, OLP, and SCC. Methods: Immunohistochemistry for Bcl-2 was carried out using an avidin-biotin peroxidase complex method. Tissue sections were treated with mouse monoclonal antibody against Bcl-2 (124, DAKO A/S, Denmark; dilution 1/100). Immunohistochemical parameters measured included total tissue area, total stained area and intensity of stain. Results: Keratinocytes were not Bcl-2 positive in H and were sparsely positive in OLP. The number of lymphocytes stained with Bcl-2 was significantly lower in Has compared to patients with SCC and OLP. Bcl-2 staining was weak to moderate in OLP, and moderate to intense in SCC. Bcl-2-positive lymphocytes were more expressed in older OLP patients (>55 years), and in OLP specimens with orthokeratinized epithelium, less developed acanthosis and highest grade of lymphocyte expression. Conclusion: Bcl-2 may not serve as a prognostic biomarker in oral cancer development from OLP, but it could help in selecting patients with higher need of follow up to prevent malignancy.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus
VL  - 15
IS  - 2
SP  - 362
EP  - 368
UR  - https://hdl.handle.net/21.15107/rcub_smile_1591
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Raybaud, Helene and Montei, R. and Čakić, Saša and Đurić, M. and Janković, Ljiljana",
year = "2010",
abstract = "Purpose: The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of the expression of the Bcl-2 marker in healthy individuals (H), patients with OLP and patients with squamous cell carcinoma (SCC), and to establish potential interdependence between expression of Bcl-2 and the different clinical and histopathological parameters in H, OLP, and SCC. Methods: Immunohistochemistry for Bcl-2 was carried out using an avidin-biotin peroxidase complex method. Tissue sections were treated with mouse monoclonal antibody against Bcl-2 (124, DAKO A/S, Denmark; dilution 1/100). Immunohistochemical parameters measured included total tissue area, total stained area and intensity of stain. Results: Keratinocytes were not Bcl-2 positive in H and were sparsely positive in OLP. The number of lymphocytes stained with Bcl-2 was significantly lower in Has compared to patients with SCC and OLP. Bcl-2 staining was weak to moderate in OLP, and moderate to intense in SCC. Bcl-2-positive lymphocytes were more expressed in older OLP patients (>55 years), and in OLP specimens with orthokeratinized epithelium, less developed acanthosis and highest grade of lymphocyte expression. Conclusion: Bcl-2 may not serve as a prognostic biomarker in oral cancer development from OLP, but it could help in selecting patients with higher need of follow up to prevent malignancy.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus",
volume = "15",
number = "2",
pages = "362-368",
url = "https://hdl.handle.net/21.15107/rcub_smile_1591"
}
Hadži-Mihailović, M., Raybaud, H., Montei, R., Čakić, S., Đurić, M.,& Janković, L.. (2010). Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 15(2), 362-368.
https://hdl.handle.net/21.15107/rcub_smile_1591
Hadži-Mihailović M, Raybaud H, Montei R, Čakić S, Đurić M, Janković L. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. in Journal of BUON. 2010;15(2):362-368.
https://hdl.handle.net/21.15107/rcub_smile_1591 .
Hadži-Mihailović, Miloš, Raybaud, Helene, Montei, R., Čakić, Saša, Đurić, M., Janković, Ljiljana, "Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus" in Journal of BUON, 15, no. 2 (2010):362-368,
https://hdl.handle.net/21.15107/rcub_smile_1591 .
8

Oral status in patients receiving 5-fluorouracil for colorectal cancer

Đurić, M.; Čakić, Saša; Hadži-Mihailović, Miloš; Petrović, D.; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2010)

TY  - JOUR
AU  - Đurić, M.
AU  - Čakić, Saša
AU  - Hadži-Mihailović, Miloš
AU  - Petrović, D.
AU  - Janković, Ljiljana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1562
AB  - Purpose: Oral complications are frequent and troublesome symptoms for those undergoing chemotherapy for cancer Several antineoplastic agents are proved to have stomatotoxic potential, among them 5-fluorouracil (5-FU). The aim of the present study was to evaluate the oral status and patient experiences during chemotherapy with 5-FU for colorectal cancer Methods: Twenty-eight patients treated with 5-day 5-FU plus leucovorin entered this study. Positive data about oral symptoms were taken by anamnesis. Mucositis severity index, gingival index, plaque index, probing pocket depth and bleeding on probing have been used to assess oral mucosa and periodontal status of the patients. Patients were examined prior to chemotherapy and 14 days after the start of the chemotherapy cycle. Results: Mild to moderate subjective complaints concerning oral cavity were reported by 17.9% of patients before and 39.2% of patients after chemotherapy. Clinical examination revealed oral mucosa damage in 10.7% and 35.7% of patients, with mean mucositis score of 0.14 and 0.54 before and after chemotherapy, respectively. Although mean values of all periodontal indices were elevated after chemotherapy, only increase in gingival index was statistically significant (p=0.035). Mucositis was significantly correlated with oral pain (p=0.00), xerostomia (p=0.00), and plaque index (p=0.077), while the correlation between mucositis and the rest of the examined parameters was not significant. Conclusion: Oral complications were not highly expressed in this study Although 5-FU is considered to exert significant stomatotoxic effect, severe mucositis was far less common in this study compared to studies reported elsewhere.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Oral status in patients receiving 5-fluorouracil for colorectal cancer
VL  - 15
IS  - 3
SP  - 475
EP  - 479
UR  - https://hdl.handle.net/21.15107/rcub_smile_1562
ER  - 
@article{
author = "Đurić, M. and Čakić, Saša and Hadži-Mihailović, Miloš and Petrović, D. and Janković, Ljiljana",
year = "2010",
abstract = "Purpose: Oral complications are frequent and troublesome symptoms for those undergoing chemotherapy for cancer Several antineoplastic agents are proved to have stomatotoxic potential, among them 5-fluorouracil (5-FU). The aim of the present study was to evaluate the oral status and patient experiences during chemotherapy with 5-FU for colorectal cancer Methods: Twenty-eight patients treated with 5-day 5-FU plus leucovorin entered this study. Positive data about oral symptoms were taken by anamnesis. Mucositis severity index, gingival index, plaque index, probing pocket depth and bleeding on probing have been used to assess oral mucosa and periodontal status of the patients. Patients were examined prior to chemotherapy and 14 days after the start of the chemotherapy cycle. Results: Mild to moderate subjective complaints concerning oral cavity were reported by 17.9% of patients before and 39.2% of patients after chemotherapy. Clinical examination revealed oral mucosa damage in 10.7% and 35.7% of patients, with mean mucositis score of 0.14 and 0.54 before and after chemotherapy, respectively. Although mean values of all periodontal indices were elevated after chemotherapy, only increase in gingival index was statistically significant (p=0.035). Mucositis was significantly correlated with oral pain (p=0.00), xerostomia (p=0.00), and plaque index (p=0.077), while the correlation between mucositis and the rest of the examined parameters was not significant. Conclusion: Oral complications were not highly expressed in this study Although 5-FU is considered to exert significant stomatotoxic effect, severe mucositis was far less common in this study compared to studies reported elsewhere.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Oral status in patients receiving 5-fluorouracil for colorectal cancer",
volume = "15",
number = "3",
pages = "475-479",
url = "https://hdl.handle.net/21.15107/rcub_smile_1562"
}
Đurić, M., Čakić, S., Hadži-Mihailović, M., Petrović, D.,& Janković, L.. (2010). Oral status in patients receiving 5-fluorouracil for colorectal cancer. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 15(3), 475-479.
https://hdl.handle.net/21.15107/rcub_smile_1562
Đurić M, Čakić S, Hadži-Mihailović M, Petrović D, Janković L. Oral status in patients receiving 5-fluorouracil for colorectal cancer. in Journal of BUON. 2010;15(3):475-479.
https://hdl.handle.net/21.15107/rcub_smile_1562 .
Đurić, M., Čakić, Saša, Hadži-Mihailović, Miloš, Petrović, D., Janković, Ljiljana, "Oral status in patients receiving 5-fluorouracil for colorectal cancer" in Journal of BUON, 15, no. 3 (2010):475-479,
https://hdl.handle.net/21.15107/rcub_smile_1562 .
6

Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy

Đurić, M.; Pavlica, Dušan; Janković, L.; Milašin, Jelena; Jovanović, T.

(Sage Publications Ltd, London, 2007)

TY  - JOUR
AU  - Đurić, M.
AU  - Pavlica, Dušan
AU  - Janković, L.
AU  - Milašin, Jelena
AU  - Jovanović, T.
PY  - 2007
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1344
AB  - Background The aim of this study was to confirm the presence of herpes simplex virus type 1 and 2 on the oral mucosa, in patients undergoing chemotherapy, by means of polymerase chain reaction (PCR). Methods The research was carried out on 40 patients receiving chemotherapy as treatment for different malignancies. The status of oral mucosa and viral presence were assessed in all patients at the initial examination (prior to chemotherapy), and at the control examination (two weeks after the initiation of the chemotherapeutic cycle). Results The presence of HSV-1 was detected in 28 patients (70%) prior to chemotherapy, of whom 7 (25%) manifested oral complications. The control examination showed the presence of HSV-1 in 35 patients (87.5%), of whom 23 (65.7%) presented oral mucosa changes. HSV-2 has not been detected in any of the patients.
PB  - Sage Publications Ltd, London
T2  - Scottish Medical Journal
T1  - Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy
VL  - 52
IS  - 1
SP  - 28
EP  - 31
DO  - 10.1258/rsmsmj.52.1.28
ER  - 
@article{
author = "Đurić, M. and Pavlica, Dušan and Janković, L. and Milašin, Jelena and Jovanović, T.",
year = "2007",
abstract = "Background The aim of this study was to confirm the presence of herpes simplex virus type 1 and 2 on the oral mucosa, in patients undergoing chemotherapy, by means of polymerase chain reaction (PCR). Methods The research was carried out on 40 patients receiving chemotherapy as treatment for different malignancies. The status of oral mucosa and viral presence were assessed in all patients at the initial examination (prior to chemotherapy), and at the control examination (two weeks after the initiation of the chemotherapeutic cycle). Results The presence of HSV-1 was detected in 28 patients (70%) prior to chemotherapy, of whom 7 (25%) manifested oral complications. The control examination showed the presence of HSV-1 in 35 patients (87.5%), of whom 23 (65.7%) presented oral mucosa changes. HSV-2 has not been detected in any of the patients.",
publisher = "Sage Publications Ltd, London",
journal = "Scottish Medical Journal",
title = "Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy",
volume = "52",
number = "1",
pages = "28-31",
doi = "10.1258/rsmsmj.52.1.28"
}
Đurić, M., Pavlica, D., Janković, L., Milašin, J.,& Jovanović, T.. (2007). Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy. in Scottish Medical Journal
Sage Publications Ltd, London., 52(1), 28-31.
https://doi.org/10.1258/rsmsmj.52.1.28
Đurić M, Pavlica D, Janković L, Milašin J, Jovanović T. Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy. in Scottish Medical Journal. 2007;52(1):28-31.
doi:10.1258/rsmsmj.52.1.28 .
Đurić, M., Pavlica, Dušan, Janković, L., Milašin, Jelena, Jovanović, T., "Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy" in Scottish Medical Journal, 52, no. 1 (2007):28-31,
https://doi.org/10.1258/rsmsmj.52.1.28 . .
3
2
3